ANTH
Anthera Pharmaceuticals, Inc.
ANTH
ANTH
Delisted
ANTH was delisted on the 27th of June, 2018.
37 hedge funds and large institutions have $17.9M invested in Anthera Pharmaceuticals, Inc. in 2014 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
37
Holders Change
+2
Holders Change %
+5.71%
% of All Funds
0.99%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
9
Increased
10
Reduced
7
Closed
6
Calls
$8K
Puts
$46K
Net Calls
-$38K
Net Calls Change
+$70K
Top Buyers
1 |
BC
Broadfin Capital
New York
|
+$762K |
2 |
![]()
Franklin Resources
San Mateo,
California
|
+$622K |
3 |
GCM
Gruss Capital Management
New York
|
+$158K |
4 |
SIM
Spark Investment Management
New York
|
+$104K |
5 |
HighTower Advisors
Chicago,
Illinois
|
+$89K |